These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14693772)

  • 1. Bioavailability of fluorescein from a new drug delivery system in human eyes.
    Steinfeld A; Lux A; Maier S; Süverkrüp R; Diestelhorst M
    Br J Ophthalmol; 2004 Jan; 88(1):48-53. PubMed ID: 14693772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative bioavailability study of three conventional eye drops versus a single lyophilisate.
    Lux A; Maier S; Dinslage S; Süverkrüp R; Diestelhorst M
    Br J Ophthalmol; 2003 Apr; 87(4):436-40. PubMed ID: 12642306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye drops.
    Abduljalil K; Diestelhorst M; Doroshyenko O; Lux A; Steinfeld A; Dinslage S; Süverkrüp R; Fuhr U
    Eur J Clin Pharmacol; 2008 May; 64(5):521-9. PubMed ID: 18219479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lyophilisates for drug delivery in ophthalmology: pharmacokinetics of fluorescein in the human anterior segment.
    Dinslage S; Diestelhorst M; Weichselbaum A; Süverkrüp R
    Br J Ophthalmol; 2002 Oct; 86(10):1114-7. PubMed ID: 12234889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Three conventional eye drops versus a single lyophilisate. A comparative bioavailability study].
    Lux A; Dinslage S; Süverkrüp R; Maier S; Diestelhorst M
    J Fr Ophtalmol; 2005 Feb; 28(2):185-9. PubMed ID: 15851952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of consecutively applied fluorescein eye drops on corneal and aqueous concentrations of fluorescein.
    Lindén C; Alm A
    Ophthalmic Res; 1997; 29(2):57-60. PubMed ID: 9154530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorophotometry as a diagnostic tool for the evaluation of dry eye disease.
    Fahim MM; Haji S; Koonapareddy CV; Fan VC; Asbell PA
    BMC Ophthalmol; 2006 May; 6():20. PubMed ID: 16729882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of fluorescein to the anterior chamber using the corneal collagen shield.
    Reidy JJ; Limberg M; Kaufman HE
    Ophthalmology; 1990 Sep; 97(9):1201-3. PubMed ID: 2234854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ophthalmic lyophilisate carrier system (OLCS): development of a novel dosage form, freeze-drying technique, and in vitro quality control tests.
    Süverkrüp R; Grunthal S; Krasichkova O; Maier S; Weichselbaum A; Neff B; Diestelhorst M; Dinslage S; Lux A
    Eur J Pharm Biopharm; 2004 Mar; 57(2):269-77. PubMed ID: 15018984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of topically applied fluorescein into eyes with avascular filtering bleb after trabeculectomy.
    Matsuo H; Tomidokoro A; Araie M
    Am J Ophthalmol; 2005 Oct; 140(4):742-4. PubMed ID: 16226534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Spray Device to Deliver Topical Ocular Medication: Penetration of Fluorescein to the Anterior Segment.
    van Rooij J; Wubbels RJ; de Kruijf WP
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):531-5. PubMed ID: 26062091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated anterior chamber fluorophotometric evaluation of the eyes of ophthalmologically normal dogs.
    Miller VS; Allbaugh RA; Roush JK; Rankin AJ
    Am J Vet Res; 2012 Oct; 73(10):1503-6. PubMed ID: 23013174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
    Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
    Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intracanalicular collagen implants on the absorption of topically applied sodium fluorescein.
    Unterman SR; Reidy JJ; Hill JH; Kaufman HE
    Cornea; 1991 Nov; 10(6):516-8. PubMed ID: 1782780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption of fluorescein given under the upper lid.
    Wong EK; Lum C; To Y; Pan C; Kim L; Gureghian E
    Ophthalmology; 1994 Jan; 101(1):182-7. PubMed ID: 8302553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ measurement of fluorescein release by collagen shields in human eyes.
    Srinivas SP
    Curr Eye Res; 1994 Apr; 13(4):281-8. PubMed ID: 7518372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive, direct, real time measurement of drug concentration in the anterior eye.
    Miller J; Wilson WS; Wilson CG; Uttamchandani D
    Br J Ophthalmol; 2005 Sep; 89(9):1147-51. PubMed ID: 16113370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal permeability changes in dry eye disease: an observational study.
    Fujitani K; Gadaria N; Lee KI; Barry B; Asbell P
    BMC Ophthalmol; 2016 May; 16(1):53. PubMed ID: 27177442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry Drops: a new preservative-free drug delivery system.
    Diestelhorst M; Grunthal S; Süverkrüp R
    Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):394-8. PubMed ID: 10333106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of gentamicin to the rabbit eye by drug-loaded hydrogel iontophoresis.
    Eljarrat-Binstock E; Raiskup F; Stepensky D; Domb AJ; Frucht-Pery J
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2543-8. PubMed ID: 15277475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.